Protalix BioTherapeutics, Inc. (PLX)
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials for the treatment of Fabry diseases; PRX-110, a proprietary plant cell recombinant form of human deoxyribonuclease I that has completed phase IIa clinical trials for the treatment of cystic fibrosis; PRX-115, a plant cell-expressed recombinant PEGylated Uricase for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz (Fiocruz); and Chiesi Farmaceutici S.p.A. The company was founded in 1993 and is based in Hackensack, New Jersey.
$84.57M
Mr. Dror Bashan
202.00
Hackensack, NJ
Sep 06, 2010
-5.00
$-0.23
0.40
1.33
-38.61%
-5.49
-0.58
2.82
2.13
0.98
-16.05%
-45.15%
Similar stocks (12)
Iovance Biotherapeutics, Inc.
IOVA
Lexicon Pharmaceuticals, Inc.
LXRX
Aldeyra Therapeutics, Inc.
ALDX
Corvus Pharmaceuticals, Inc.
CRVS
Akebia Therapeutics, Inc.
AKBA
Seres Therapeutics, Inc.
MCRB
X4 Pharmaceuticals, Inc.
XFOR
PDS Biotechnology Corporation
PDSB
Checkpoint Therapeutics, Inc.
CKPT
Cidara Therapeutics, Inc.
CDTX
Elevation Oncology, Inc.
ELEV
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (7)
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
0.05369677%
Xtrackers MSCI Eurozone Hedged Equity ETF
DBEZ
0.0319961%
iShares Micro-Cap ETF
IWC
0.02019%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
0.016663%
SPDR Portfolio Europe ETF
SPEU
0.013365%
Schwab International Equity ETF
SCHF
0.0121838724%
SPDR Portfolio Developed World ex-US ETF
SPDW
0.008951%
Similar stocks (12)
Iovance Biotherapeutics, Inc.
IOVA
Lexicon Pharmaceuticals, Inc.
LXRX
Aldeyra Therapeutics, Inc.
ALDX
Corvus Pharmaceuticals, Inc.
CRVS
Akebia Therapeutics, Inc.
AKBA
Seres Therapeutics, Inc.
MCRB
X4 Pharmaceuticals, Inc.
XFOR
PDS Biotechnology Corporation
PDSB
Checkpoint Therapeutics, Inc.
CKPT
Cidara Therapeutics, Inc.
CDTX
Elevation Oncology, Inc.
ELEV
eFFECTOR Therapeutics, Inc.
EFTR
ETF Exposure (7)
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
0.05369677%
Xtrackers MSCI Eurozone Hedged Equity ETF
DBEZ
0.0319961%
iShares Micro-Cap ETF
IWC
0.02019%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
0.016663%
SPDR Portfolio Europe ETF
SPEU
0.013365%
Schwab International Equity ETF
SCHF
0.0121838724%
SPDR Portfolio Developed World ex-US ETF
SPDW
0.008951%